Filter posts

Investment Market Good for Deal-making at #BIF18

As we move into the final quarter of 2018, we reflect on a year with …

Digital Health Innovation to be Spotlighted at the BIO Investor Forum

Is your company trying to expand into “digiceuticals” or digital therapeutics? Are you looking to …

Bull Market Bodes Well for #BIF18

The rapid pace of scientific discovery, FDA approvals, commercialization of medicines held long in pipelines, …

Announcing BUZZ of BIO Winners for the 2018 BIO Investor Forum

BIO is pleased to announce the winners of the 2018 BIO Investor Forum Buzz of BIO contest, which recognizes …

Win a Free Company Presentation at #BIF18 with the Buzz of BIO Contest

The Buzz of BIO contest provides an excellent opportunity for companies looking to gain exposure …

Early-Stage Portfolios Can Win Over Active Investors at BIO Investor Forum

This fall more than 200 biotech CEOs from 25 different countries will attend the 17th …

“Diverse Candidates Can Win If They Can Get the Interview.”

Diversity is gaining more attention among biotech investors and companies alike. At entry level, 50% …

#BIF17: Looking Ahead to 2018 Policy Landscape

The past year has seen a number of important changes in the legislative and policy …

A Discussion on Value at #BIF17

In a recent op-ed, BIO President and CEO Jim Greenwood wrote about a promising trend …

“Invest in What’s Cool. Invest in Science that Matters.”

One reality of the biotech industry that’s often overlooked is that 90% of biotech companies …